New hope for HAE patients: experimental drug aims to slash attack rate
NCT ID NCT06846398
First seen Mar 12, 2026 · Last updated Apr 30, 2026 · Updated 9 times
Summary
This study tests an experimental drug called BW-20805 in 25 adults with hereditary angioedema (HAE), a condition that causes sudden, painful swelling attacks. The goal is to see if the drug can reduce how often these attacks happen over 24 weeks. Participants will receive the drug and be monitored for safety and effectiveness for up to 96 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA (HAE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedale - Universita di Padova
Padova, PD, 35128, Italy
-
Azienda Ospedaliero Universitaria Policlinico G. Rodolico San Marco - Ospedale San Marco
Catania, Catania, 95125, Italy
-
Azienda Ospedaliero-Universitaria Careggi
Florence, Florence, 50134, Italy
-
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, 12200, Germany
-
Duke University Medicine Center
Durham, North Carolina, 27705, United States
-
First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, 650032, China
-
Hospital Universitario Virgen del Rocío
Seville, Sevilla, 41013, Spain
-
Inova Clinical Trials and Research Center
Falls Church, Virginia, 22031, United States
-
Institute for Asthma and Allergy - Wheaton
Silver Spring, Maryland, 20902, United States
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
-
Penn State Milton S. Hershey MC - Penn State
Hershey, Pennsylvania, 17033, United States
-
SP ZOZ Szpital Uniwersytecki w Krakowie
Krakow, Lesser Poland Voivodeship, 31-066, Poland
-
The First Hospital of Lanzhou University
Lanzhou, Gansu, 730000, China
-
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, 130030, China
-
Universitätsmedizin der Johannes Gutenberg
Mainz, Rhineland-Palatinate, 55101, Germany
-
Washington University School of Medicine
St Louis, Missouri, 63141, United States
-
West China Hospital, Sichuan University
Chengdu, Sichaun, 610041, China
-
Yantai Yuhuangding Hospital
Yantai, Shandong, 264000, China
Conditions
Explore the condition pages connected to this study.